JPS5846100A - ３種の遺伝標識を有するプラスミドベクタ−及びその製造方法 - Google Patents
３種の遺伝標識を有するプラスミドベクタ−及びその製造方法Info
- Publication number
- JPS5846100A JPS5846100A JP56143520A JP14352081A JPS5846100A JP S5846100 A JPS5846100 A JP S5846100A JP 56143520 A JP56143520 A JP 56143520A JP 14352081 A JP14352081 A JP 14352081A JP S5846100 A JPS5846100 A JP S5846100A
- Authority
- JP
- Japan
- Prior art keywords
- resistant
- plasmid
- plasmid vector
- resistance
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013600 plasmid vector Substances 0.000 title claims abstract description 38
- 239000003550 marker Substances 0.000 title description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 31
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960001082 trimethoprim Drugs 0.000 claims abstract description 17
- 108010022394 Threonine synthase Proteins 0.000 claims abstract description 15
- 239000004098 Tetracycline Substances 0.000 claims abstract description 6
- 229960002180 tetracycline Drugs 0.000 claims abstract description 6
- 229930101283 tetracycline Natural products 0.000 claims abstract description 6
- 235000019364 tetracycline Nutrition 0.000 claims abstract description 6
- 150000003522 tetracyclines Chemical class 0.000 claims abstract description 6
- 229960000723 ampicillin Drugs 0.000 claims description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 4
- 230000002068 genetic effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000013612 plasmid Substances 0.000 abstract description 26
- 230000007017 scission Effects 0.000 abstract description 11
- 238000003780 insertion Methods 0.000 abstract description 10
- 230000037431 insertion Effects 0.000 abstract description 10
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 101710163270 Nuclease Proteins 0.000 abstract description 8
- 241001646716 Escherichia coli K-12 Species 0.000 abstract description 3
- 238000010504 bond cleavage reaction Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 32
- 108091008146 restriction endonucleases Proteins 0.000 description 18
- 238000003776 cleavage reaction Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229960001931 ampicillin sodium Drugs 0.000 description 5
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 102000004419 dihydrofolate reductase Human genes 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000006916 nutrient agar Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000029087 digestion Effects 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 101710149086 Nuclease S1 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- 241000841159 Anaka Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56143520A JPS5846100A (ja) | 1981-09-11 | 1981-09-11 | ３種の遺伝標識を有するプラスミドベクタ−及びその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56143520A JPS5846100A (ja) | 1981-09-11 | 1981-09-11 | ３種の遺伝標識を有するプラスミドベクタ−及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5846100A true JPS5846100A (ja) | 1983-03-17 |
| JPS6135831B2 JPS6135831B2 (enrdf_load_stackoverflow) | 1986-08-15 |
Family
ID=15340644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56143520A Granted JPS5846100A (ja) | 1981-09-11 | 1981-09-11 | ３種の遺伝標識を有するプラスミドベクタ−及びその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5846100A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59198979A (ja) * | 1983-04-28 | 1984-11-10 | Agency Of Ind Science & Technol | 特定プラスミドを含む宿主菌体の安定化 |
| JPH09117293A (ja) * | 1986-07-19 | 1997-05-06 | Behringwerke Ag | ヒトアンチトロンビンｉｉｉ（ａｔｉｉｉ）の製造 |
-
1981
- 1981-09-11 JP JP56143520A patent/JPS5846100A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59198979A (ja) * | 1983-04-28 | 1984-11-10 | Agency Of Ind Science & Technol | 特定プラスミドを含む宿主菌体の安定化 |
| JPH09117293A (ja) * | 1986-07-19 | 1997-05-06 | Behringwerke Ag | ヒトアンチトロンビンｉｉｉ（ａｔｉｉｉ）の製造 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6135831B2 (enrdf_load_stackoverflow) | 1986-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gritz et al. | Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae | |
| FI86886B (fi) | Nya expressionsplasmider och deras anvaendning i foerfarandet foer expressering av prokymosin koderande gen i e.coli. | |
| Morisato et al. | Tn10 transposition and circle formation in vitro | |
| Rogers et al. | Insertional activation of cepA leads to high-level beta-lactamase expression in Bacteroides fragilis clinical isolates | |
| JPH0253489A (ja) | メチロトローフ酵母のアルコールオキシダーゼ２調節領域をコードするｄｎａ配列 | |
| IWASAKI et al. | Molecular cloning of a xylanase gene from Streptomyces sp. No. 36a and its expression in streptomycetes | |
| JP2574142B2 (ja) | 組換えリシン毒素フラグメント | |
| JPS5846100A (ja) | ３種の遺伝標識を有するプラスミドベクタ−及びその製造方法 | |
| Little | Isolation of recombinant plasmids and phage carrying the lexA gene of Escherichia coli Kl 2 | |
| EP0037273A2 (en) | Modification of micro-organisms | |
| EP0198645A1 (en) | Human pancreatic elastase | |
| IE863080L (en) | Expression in lactic acid bacteria | |
| IE57985B1 (en) | Improved plasmid vector and use thereof | |
| de Mendoza et al. | One-step gene amplification by Mu-mediated transposition of E. coli genes to a multicopy plasmid | |
| Hoshino et al. | Genetic analysis of the Pseudomonas aeruginosa PAO high-affinity branched-chain amino acid transport system by use of plasmids carrying the bra genes | |
| JPS60126087A (ja) | プロモ−タ・クロ−ニング用プラスミドｐＴＰ１８−２，ｐＴＰ１８−４及びｐＴＰ１８−６ | |
| JPS62296881A (ja) | 酵母ｄｎａフラグメント及びその利用 | |
| JP2992635B1 (ja) | プラスミド | |
| JP3024766B2 (ja) | トリプトファン生産能を有する乳酸桿菌 | |
| EP0154351A2 (en) | Expression plasmids useful in B. subtilis | |
| SU1250174A3 (ru) | Способ получени гибридных плазмид,содержащих структурные гены и вектор,передающий устройчивость к гигромицину в и G 418 | |
| JPS60199385A (ja) | プラスミドベクタ−ｐＴＰ２０−１０ | |
| CN117660419A (zh) | 水解活性提高的胶原酶及其应用 | |
| JPS62143685A (ja) | 新規な耐熱性β−ガラクトシダ−ゼ及びそれをコ−ドする遺伝子 | |
| JPH0789933B2 (ja) | プラスミド |